skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PharmaLogo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

960 Total results for product and free and sample content found

Meddevicetracker

Robotic Surgery 4.0 Innovative Robotic Assisted Systems & their Applications

By Tina Tan 15 Jun 2018

The webinar will provide a thought leadership perspective on the key challenges and trends in the emerging Robotic Surgery market.

Topic Digital Health Research

Full webinar

Medtech Insight

Procept BioRobotics Believes Aquablation Could Dominate BPH Treatment... If It Gets Coverage

By Reed Miller 14 Jun 2018

Results of the WATER II trial confirm that Aquablation is a safe and effective treatment of benign prostate hyperplasia for large prostates, and manufacturer Procept BioRobotics is confident the procedure will eventually displace all other prostate resection techniques because it is easy for surgeons to learn.

Topic Company analysis Business strategies

View article

In Vivo

World In Motion The Shape Of The New Health Care Technology Ecosystem In 2022

By Ashley Yeo 14 Jun 2018

The health products industry, methods of care delivery and even the public's expectations for improved tools to prevent, monitor and treat disease have transformed dramatically in the past five years. The changes anticipated over a similar period ahead are potentially even more marked, with business continuity impacts for medtech and pharma concerns, according to Deloitte LLP experts who were on the circuit at health care industry events in Germany and the UK this spring.

Topic Business strategies Digital Health

View article

In Vivo

How The EHR And New Data Streams Are Influencing Clinical Practice

By Mark Ratner 14 Jun 2018

A plethora of clinical studies are showing that new types of data, often captured in the EHR, can help improve the correlation between treatments and outcomes and favorably affect patient care as well as enhance drug development.

View article

Pink Sheet

US FDA's Plan On Right To Try: Big On Congressional Engagement, Short On Policy Details

By Sue Sutter 14 Jun 2018

Internal group headed by Principal Deputy Commissioner Rachel Sherman will develop implementation recommendations, which could include new guidance, regulations, a Q&A document or ‘nothing at all,’ Commissioner Gottlieb tells BIO annual meeting; he promises consultation with the law’s supporters and critics on Capitol Hill ‘to fully understand what the intent was with different provisions.’

Topic FDA

View article

Pink Sheet

FDA Finally Approves Avastin In First-Line Ovarian Cancer

By Emily Hayes 14 Jun 2018

Genentech says it worked closely with the agency to bring the drug to women with earlier-stage disease.

Topic Cancer FDA

View article

Medtech Insight

New Reasons Not To Use EU MDR's Four-Year Extension, But Comply Earlier Or Retire Products Instead

By Amanda Maxwell 14 Jun 2018

The new EU Medical Device Regulation offers companies an option to market CE-marked devices for an extra four years under current directives. But more hurdles are being identified that make this option less attractive.

Topic Brexit Business strategies

View article

Scrip

Aim High And Keep Pushing China Biotech Dealmakers Borrow Page From Trump

By Brian Yang 14 Jun 2018

Recent biotech investment deals involving WuXi, Oncologie and Siranomics show Chinese investors are becoming increasingly bold and savvy in betting on innovative assets both inside and outside the country.

Topic BioPharmaceutical

View article

Scrip

Levin Calls Takeda Shire Merger Inspired Says Entire Value Chain Must Address Pricing Issue

By Joseph Haas 14 Jun 2018

Having previously criticized the biopharma industry for squandering the benefits of US tax reform, the former Teva CEO called for more M&A deals that offer a clear strategic rationale, pointing to Takeda/Shire as an example.

Topic BioPharmaceutical

View article
Show More

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.
General enquiry

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now